Goldline Pharmaceutical Ltd.
GLPL
Goldline Pharmaceutical Ltd. Share Price
43.67 0.00 (0.00%)Fundamentals
Market Cap₹42Cr | EPS₹5.97 |
Industry P/E (TTM)40.68 | P/B Ratio4.11 |
Long Term D/E0.64 | ROE33.46% |
Dividend Yield (TTM)0.00% |
FAQs on Goldline Pharmaceutical Ltd.
What is the share price of Goldline Pharmaceutical Ltd.?
The share price of Goldline Pharmaceutical Ltd. is ₹43.67 on BSE as of 19/6/2026, 9:18:22 am. Share prices may change frequently due to market movements.
What is the market capitalisation of Goldline Pharmaceutical Ltd.?
The market capitalisation of Goldline Pharmaceutical Ltd. is ₹42Cr as of 19/6/2026, 9:18:22 am
What is the current P/E ratio of Goldline Pharmaceutical Ltd.?
The current Price to Earnings (P/E) ratio of Goldline Pharmaceutical Ltd. is 0.00 as of 19/6/2026, 9:18:22 am
What is the current P/B ratio of Goldline Pharmaceutical Ltd.?
The Price to Book (P/B) ratio of Goldline Pharmaceutical Ltd. stands at 4.12 as of 19/6/2026, 9:18:22 am
What is the ROE of Goldline Pharmaceutical Ltd.?
Goldline Pharmaceutical Ltd. reported an ROE of 33.47% for the last reported financial year on a consolidated account basis.
What is the shareholding pattern of Goldline Pharmaceutical Ltd.?
As of 19/6/2026, 9:18:22 am, Goldline Pharmaceutical Ltd.’s shareholding pattern is: promoters hold undefined%, FIIs hold undefined%, DIIs hold undefined%, and public shareholders hold undefined%.
What is the stock symbol of Goldline Pharmaceutical Ltd.?
The stock symbol of Goldline Pharmaceutical Ltd. is GLPL.
How to buy Goldline Pharmaceutical Ltd.?
You can buy Goldline Pharmaceutical Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.
What is the fair value of Goldline Pharmaceutical Ltd.?
The fair value of Goldline Pharmaceutical Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
| Particulars (in Cr) | Mar 2026 | Y/Y Change |
|---|---|---|
| Operating Revenue | 31.20 | +11.19% |
| Other Income | 0.00 | - |
| Total Income | 31.20 | +11.19% |
| Total Expenditure | 25.81 | +6.65% |
| EBIDT | 6.94 | +19.04% |
| Depreciation | 0.24 | -4.00% |
| Interest | 1.31 | -23.84% |
| Tax | 1.27 | +24.51% |
| Net Profit | 4.12 | +45.58% |
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Total Current Assets | 26.05 |
| Total Non-Current Assets | 2.82 |
| Fixed assets | 2.71 |
| Total Assets | 28.87 |
| Total Current liabilities | 12.11 |
| Total Non Current Liabilities | 2.51 |
| Total Equity Plus Liabilities | 28.87 |
| Total Shareholder Funds | 14.25 |
| Total Debt to Equity | 74.00% |
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Cash from Operating Activity | 2.81 |
| Cash from Financing Activities | -3.40 |
| Cash from Investing Activities | -0.06 |
| Net Cash Flow | -0.65 |
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages0
Bearish Moving Averages7
5 Day
44.5010 Day
45.2020 Day
45.60Indicators
RSI (14)
33.44MACD (12, 26)
--MACD Signal Line (9)
--MFI (14)
18.59ATR (14)
3.22ADX (14)
--ROC (21)
-23.08ROC (125)
--Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 45.24 | 46.82 | 48.73 | 43.33 | 41.75 | 39.84 | 38.26 |
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
Goldline Pharmaceutical Ltd.
GLPL
Open Price | 0.00 |
Prev Close | 43.67 |
Upper Circuit | 52.40 |
Lower Circuit | 34.94 |
Volume | 0 |
Average Traded Price | 0.00 |
Historical Performance
| 1 Day | NA |
| 5 Days | NA |
| 1 Month | NA |
| 3 Months | NA |
| 1 Year | NA |
| 5 Years | NA |
| 10 Years | NA |